(Q41282498)

29 September 2017

1 reference

title

New developments in biochemical markers for osteoporosis (English)

1 reference

29 September 2017

0 references

P Garnero

1

1 reference

29 September 2017

P D Delmas

series ordinal

2

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 January 1996

1 reference

Calcified Tissue International

29 September 2017

1 reference

29 September 2017

59 Suppl 1

1 reference

29 September 2017

S2-9

1 reference

https://scigraph.springernature.com/pub.10.1007/s002239900168

29 September 2017

0 references

cites work

Bone turnover in spinal osteoporosis.

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

The preparation of monoclonal antibodies which react preferentially with human bone alkaline phosphatase and not liver alkaline phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. Comparison with bone histomorphometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Multiple immunoreactive forms of osteocalcin in uremic serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Multiple osteocalcin fragments in human urine and serum as detected by a midmolecule osteocalcin radioimmunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Circulating C-terminal propeptide of type I procollagen is cleared mainly via the mannose receptor in liver endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

The biosynthesis of collagen and its disorders (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Collagen cross-linking in human bone and articular cartilage. Age-related changes in the content of mature hydroxypyridinium residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Urinary pyridinium crosslinks of collagen: specific markers of bone resorption in metabolic bone disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Immunoassay for urinary pyridinoline: the new marker of bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Sex steroids and bone mass. A study of changes about the time of menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Low bone mass and fast rate of bone loss at menopause: equal risk factors for future fracture: a 15-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Dietary supplementation in elderly patients with fractured neck of the femur

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Rise in plasma alkaline phosphatase at the menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Active bone turnover of the cortico-endosteal envelope in postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: effects of sex, age, and metabolic bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Effect of renal function on plasma levels of bone Gla-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Serum bone Gla-protein compared to bone histomorphometry in endocrine diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Serum bone gla-protein in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Comparison of monoclonal and polyclonal antibody-based immunoassays for osteocalcin: a study of sources of variation in assay results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Bone Gla protein (osteocalcin) assay standardization report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with Iliac bone formation rates and comparison with total alkaline phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

The effect of the menopause and hormone replacement therapy on serum carboxyterminal propeptide of type I collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Urinary beta-1-galactosyl-0-hydroxylysine (GH) as a marker of collagen turnover of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Serum tartrate-resistant acid phosphatase and bone mineral content in postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

The structure of pyridinoline, a collagen crosslink

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Collagen cross-linking amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Changes with age in the urinary excretion of lysyl- and hydroxylysylpyridinoline, two new markers of bone collagen turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

The carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen in serum as a marker of bone resorption: the effect of nandrolone decanoate and hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Changes in osteocalcin after femoral neck fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Impairment of bone turnover in elderly women with hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900168

Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone

21 January 2018

1 reference

12 December 2020

Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment

1 reference

12 December 2020

Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease

1 reference

12 December 2020

Alkaline phosphatase isoenzymes

1 reference

12 December 2020

Acid phosphatases in human plasma.

1 reference

12 December 2020

Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets.

1 reference

12 December 2020

The effect of calcium supplementation on the circadian rhythm of bone resorption

1 reference

12 December 2020

Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation

1 reference

12 December 2020

Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease

1 reference

12 December 2020

Immunoassay of a tartrate-resistant acid phosphatase in serum.

1 reference

12 December 2020

Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease

1 reference

12 December 2020

Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women

1 reference

12 December 2020

Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's disease

1 reference

12 December 2020

Immunoassay for quantifying type I collagen degradation products in urine evaluated

1 reference

12 December 2020

Improved method for quantitative determination in serum of alkaline phosphatase of skeletal origin

1 reference

12 December 2020

The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women

1 reference

12 December 2020

Osteocalcin. Biochemical considerations and clinical applications

1 reference

12 December 2020

Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis

1 reference

12 December 2020

Identifiers

DOI

10.1007/S002239900168

1 reference

Dimensions Publication ID

29 September 2017

0 references

1 reference